Recently, IFITM1 was found to be highly expressed in metastatic CRC cell lines as well as colorectal patient‐derived tumor samples, and its high expression is associated with a poor prognosis of the disease 14, 15, or a more advanced clinical stage 16. This evidence concerns the gene IFITM1 and colorectal carcinoma.